HALOPERIDOL
- Product NDC
- 82619-105
- 11-digit product format
- 826190105
- Labeler code
- 82619
- Product ID
- 82619-105_46d58435-0437-e206-e063-6294a90ae755
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- haloperidol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Creekwood Pharmaceuticals LLC
- Application
- ANDA218162
- Marketing category
- ANDA
- Marketing start
- 2026-01-05
- Substance
- HALOPERIDOL
- Active strength
- .5 mg/1
- Pharmacologic classes
- Typical Antipsychotic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- HALOPERIDOL
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| HALOPERIDOL | .5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | J6292F8L3D |
| Rxcui | 197754, 310670, 310671, 310672, 314034, 314035 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 82619-105-01 | HALOPERIDOL | 100 in 1 BOTTLE | TABLET | 100 | | 1 |
| 82619-105-02 | HALOPERIDOL | 1000 in 1 BOTTLE | TABLET | 1000 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 82619-105-01 | 82619010501 | 100 TABLET in 1 BOTTLE (82619-105-01) | 100 tablet | 2026-01-05 | No | No | Historical |
| 82619-105-02 | 82619010502 | 1000 TABLET in 1 BOTTLE (82619-105-02) | 1000 tablet | 2026-01-05 | No | No | Historical |